期刊文献+

2010-2012年肾上腺疾病研究进展 被引量:1

The advances of research on adrenal diseases from 2010 to 2012
原文传递
导出
摘要 本文回顾了2010~2012年国内外在肾上腺疾病的基础和临床研究方面的主要进展,内容包括类固醇合成因子1在肾上腺肿瘤中的诊断价值、肾上腺醛固酮分泌腺瘤的发病机制及新的诊断方法、ACTH依赖性重症库欣综合征的治疗、肾上腺意外瘤伴亚临床皮质醇增多症的治疗选择、糖尿病和骨质疏松症患者中亚临床皮质醇增多症的筛选、肾上腺网状带大结节增生、以及嗜铬细胞瘤/副神经节瘤基因的筛查等。 This article reviews the major advances of basal and clinical research on the adrenal diseases at home and abroad from 2010 to 2012. There are many advances including the diagnostic value of steroidogenic factor-1 in adrenal tumors, the pathogenesis and new diagnostic methods of aldosterone-producing adenoma, the treatment for severe ACTH-dependent Cushing's syndrome, approach to the patient with an adrenal incidentaloma and subclinical hypercortisolism, screening test for subclinical hypercortisolism in the patients with diabetes or osteoporosis, the characterization of macronodular adrenocortical hyperplasia of the zona reticularis, as well as genetic testing for pheochromocytoma and paragangliomas, etc.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2012年第7期526-532,共7页 Chinese Journal of Endocrinology and Metabolism
关键词 肾上腺疾病:类固醇合成因子1 钾通道KCNJ5 醛固酮分泌腺瘤 嗜铬细胞瘤 Adrenal disease Steroidogenic factor-1 Potassium channels KCNJ5 Aldosterone-producing adenoma Pheochromocytoma
  • 相关文献

参考文献26

  • 1Sbiera S, Schmull S, Assie G, et al. High diagnostic and prognostic value of steroidogenic factor-I expression in adrenal tumors. J Clin Endocrinol Metab, 2010,95 : E161-E171.
  • 2Carey RM. Adrenal disease update 2011. J Clin Endocrinol Metab, 2011,96:3583-3591.
  • 3Choi M, Scholl UI, Yue P, et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science, 2011,331:768-772.
  • 4Funder JW. The genetics of primary aldosteronism. Science, 2011,33 l : 685-686.
  • 5Bandulik S,Penton D, Barhanin J, et al. TASK1 and TASK3 potassium channels: determinants of aldosterone secretion and adrenocortic- zonation. Hom- Metab Res, 2010,42:450-457.
  • 6onoyama T, Sone M, Miyashita K, et al. Significance of adrenocorticotropin stimulation test in the diagnosis of an aldosterone- producing adenoma. J Clin Endocrinol Metah, 2011,96:2771-2778.
  • 7Burton TJ, Mackenzie IS, Balan K, et al. Evaluation of the sensitivity and specificity of I J C-mctomidate positron emission tomography ( PET ) -CT for lateralizing aldosterone secretion by Corm' s adenoma. J Clin Endocrinol Metab, 2012,97 : 100-109.
  • 8Kamenicky P, Droumaguet C, Salenave S, et al. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome. J Clin Endocrine Metab, 2011,96:2796-2804.
  • 9Nieinan LK. Approach to the patient with an adrenal incidentaloma. J Clin Endocrinol Metab, 2010,95:4106-4l 13.
  • 10Chiodini I, Morelli V, Salcuni AS, et al. Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J Clin Endocrinol Metab, 2010, 95,2736 -2745.

二级参考文献99

  • 1张波,陆召麟,王玥,陶红.非经典型21-羟化酶缺乏症基因型和临床特征[J].中华内分泌代谢杂志,2005,21(1):43-46. 被引量:13
  • 2闫朝丽,曾正陪,童安莉,卢琳,李明,周亚茹,张晶.嗜铬细胞瘤良、恶性鉴别的临床分析[J].中华医学杂志,2005,85(43):3086-3089. 被引量:10
  • 3Waguespack SG,Rich T,Grubbs E,et al.A current review of the etiology,diagnosis,and treatment of pediatric pheochromocvtorna and paraganglioma.J Clin Endocrinol Metab,2010,95:2023-2037.
  • 4Neumann HP,Bausch B,McWhinney SR,et al.Germline mutations in nonsyndrornic pheochromocytoma.N Engl J Med,2002,346:1459-1466.
  • 5Wolffe AP,Matzke MA.Epigenetics:regulation through repression.Science,1999,286:481-486.
  • 6Serrano M.The tumor suppressor protein p16INK4a.Exp Cell Res,1997,237:7-13.
  • 7Bhattacharya SK,Ramchandani S,Cervoni N,et al.A mammalian protein with specific demetbylase activity for mCpG DNA.Nature,1999,397:579-583.
  • 8Watanabe T,Nakamura M,Yonekawa Y,et al.Promoter hypermethylation and homozygous deletion of the p14ARF and p16INK4a genes in oligodendrogliomas.Acta Neuropathol,2001,101:185-189.
  • 9Aguiar RC,Dahia PL,Sill H,et al.Deletion analysis of the p16 tumour suppressor gene in phaeochromocytomas.Clin Endocrinol (Oxf),1996,45:93-96.
  • 10Dammann R,Schagdarsurengin U,Seidel C,et al.Frequent promoter methylation of tumor-related genes in sporadic and men2-associated pheochromocytomas.Exp Clin Endocrinol Diabetes,2005,113:1-7.

共引文献23

同被引文献10

  • 1张炜,汤正义,王卫庆,吴景程,宁光.亚临床及肾上腺腺瘤型库欣综合征患者手术前后代谢综合征症状变化[J].中华内分泌代谢杂志,2006,22(6):545-548. 被引量:10
  • 2Charbonnel B,Chatal JF,Ozanne P.Does the corticoadrenal adenoma with "pre-Cushing's syndrome" exist[J]? J Nucl Med,1981,22(12):1059-1061.
  • 3Chiodini I.Clinical review:Diagnosis and treatment of subclinical hypercortisolism[J].J Clin Endocrinol Metab,2011,96 (5):1223-1236.
  • 4Latronico AC.Role of ACTH receptor in adrenocortical tumor formation[J].Braz J Med Biol Res,2000,33 (10):1249-1252.
  • 5Tsagarakis S,Vassiliadi D,Thalassinos N.Endogenous Subclinical hypercortisolism:diagnostic uncertainties and clinical implications[J].J Endocrinol Invest,2006,29 (5):471-482.
  • 6Zeiger MA,Thompson GB,Duh QY,et al.American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas[J].Endocr Pract,2009,15:1-20.
  • 7Terzolo M,Pia A,Reimondo G.Subclinical Cushing's syndrome:definition and management[J].Clin Endocrino1,2012,76 (1):12-18.
  • 8Morelli V,Masserini B,Salcuni AS,et al.Subclinical hypercortisolism:correlation between biochemical diagnostic criteria and clinical aspects[J].Clin Endocrinol(Oxf),2010,73:161-166.
  • 9张锐强,张玉石,王海,李汉忠.亚临床库欣综合征临床分析[J].中华泌尿外科杂志,2010,31(1):42-44. 被引量:4
  • 10樊华,李汉忠,石冰冰.亚临床状态肾上腺皮质肿瘤ACTH受体的表达及临床意义[J].基础医学与临床,2011,31(12):1358-1362. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部